Last updated on April 20, 2014 at 8:28 EDT

Latest Sterling Pathology National Laboratories Stories

2013-01-07 08:28:37

Diagnostic pathology firm to offer breakthrough prostate cancer assay to urology market THUNDER BAY, ON, Jan. 7, 2013 /PRNewswire/ - Mitomics, a developer of mitochondrial DNA-based tests for early disease detection, today announced it has entered into a sales and marketing agreement for the Prostate Core Mitomic Test((TM)) (PCMT(TM)) with Sterling Pathology National Laboratories. Under the agreement, Sterling Pathology National Laboratories, a leader in diagnostic pathology...